ORCA Therapeutics
PrivateLast Round
VC Round
Sep 23, 2024
Total Funding Raised
$2.73M
Company Overview
ORCA Therapeutics is a biopharmaceutical company that develops oncolytic virus immunotherapies designed to selectively kill cancer cells and induce an antitumor immune response for cancers such as prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ORCA Therapeutics Comparables
Compare ORCA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lokon Pharma | 85% | |
| TILT Biotherapeutics | 84% | |
| Theolytics | 83% | |
ORCA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2024 | ||||
| Grant | May 4, 2016 | ||||
| VC Round | Apr 1, 2016 | ||||
| Debt | Nov 8, 2011 |
ORCA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Oost NL | VC Round |
| Aglaia Oncology Funds | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2016
Secured $1.27M from the European Commission and Horizon 2020.
ORCA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ORCA Therapeutics's valuation, stock price, and market status.